Johnson & Johnson (JNJ) has paused the large Phase 3 clinical trial of its coronavirus vaccine because of an unexplained illness in one participant in the trial, the company said on Monday. The company did not say whether the sick volunteer had received the vaccine or a placebo. Johnson & Johnson, which lags some of […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
